Continue to use the Pediatric ARV Working Group (PAWG) mechanism to provide recommendations on optimal dosing and ratios for formulation development
World Health Organization (WHO)
Provide recommendations on optimal dosing and ratios for formulation development using PAWG.
Ongoing conversation on dosing and ratio for DTG/TAF/XTC.
PAWG bi-monthly meeting (every two months) calls for the year starting 12 Feb 2018.
PAWG bi-monthly meetings for 2018 restarted on February 12th, 2018. A follow-up call with Gilead is being planned to review implementation of their paediatric plan for TAF.
PAWG has continued to meet every two months and developed dosing guidance for WHO guideline update
Sub-Actions & Milestones